Wave Life Sciences (WVE) Revenue & Revenue Breakdown
Wave Life Sciences Revenue Highlights
Latest Revenue (Y)
$108.30M
Latest Revenue (Q)
$8.70M
Wave Life Sciences Revenue by Period
Wave Life Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $108.30M | -4.42% |
| 2023-12-31 | $113.31M | 3005.10% |
| 2022-12-31 | $3.65M | -91.09% |
| 2021-12-31 | $40.96M | 104.03% |
| 2020-12-31 | $20.08M | 25.61% |
| 2019-12-31 | $15.98M | 10.89% |
| 2018-12-31 | $14.41M | 289.15% |
| 2017-12-31 | $3.70M | 149.43% |
| 2016-12-31 | $1.49M | 876.97% |
| 2015-12-31 | $152.00K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Wave Life Sciences generated $108.30M in revenue during NA 2024, up -4.42% compared to the previous quarter, and up 677.61% compared to the same period a year ago.
Wave Life Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $8.70M | -5.19% |
| 2025-03-31 | $9.18M | -89.04% |
| 2024-12-31 | $83.75M | -1191.04% |
| 2024-09-30 | $-7.68M | -138.98% |
| 2024-06-30 | $19.69M | 57.06% |
| 2024-03-31 | $12.54M | -56.85% |
| 2023-12-31 | $29.06M | -40.96% |
| 2023-09-30 | $49.21M | 122.63% |
| 2023-06-30 | $22.11M | 70.98% |
| 2023-03-31 | $12.93M | 943.50% |
| 2022-12-31 | $1.24M | 334.74% |
| 2022-09-30 | $285.00K | -24.00% |
| 2022-06-30 | $375.00K | -78.57% |
| 2022-03-31 | $1.75M | -0.85% |
| 2021-12-31 | $1.76M | -95.15% |
| 2021-09-30 | $36.42M | 1212.07% |
| 2021-06-30 | $2.78M | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $9.44M | 173.59% |
| 2020-09-30 | $3.45M | 13.97% |
| 2020-06-30 | $3.03M | -27.25% |
| 2020-03-31 | $4.16M | 73.38% |
| 2019-12-31 | $2.40M | -18.06% |
| 2019-09-30 | $2.93M | -61.60% |
| 2019-06-30 | $7.63M | 152.08% |
| 2019-03-31 | $3.03M | -16.41% |
| 2018-12-31 | $3.62M | -19.43% |
| 2018-09-30 | $4.49M | -7.91% |
| 2018-06-30 | $4.88M | 243.11% |
| 2018-03-31 | $1.42M | -15.16% |
| 2017-12-31 | $1.68M | 147.93% |
| 2017-09-30 | $676.00K | - |
| 2017-06-30 | $676.00K | - |
| 2017-03-31 | $676.00K | - |
| 2016-12-31 | $676.00K | 72.45% |
| 2016-09-30 | $392.00K | -6.00% |
| 2016-06-30 | $417.00K | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $152.00K | 100.00% |
| 2015-09-30 | - | -100.00% |
| 2015-06-30 | $126.00K | 384.62% |
| 2015-03-31 | $26.00K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | - |
Wave Life Sciences generated $8.70M in revenue during Q2 2025, up -5.19% compared to the previous quarter, and up 69.38% compared to the same period a year ago.
Wave Life Sciences Revenue Breakdown
Wave Life Sciences Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 21 |
|---|---|
| Research Term | $18.50M |
Latest
Wave Life Sciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 21: Research Term (100.00%).
Wave Life Sciences Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 21 |
|---|---|
| Research Term | $18.50M |
Latest
Wave Life Sciences's latest quarterly revenue breakdown by geography, as of Jun 21: Research Term (100.00%).
Wave Life Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| WVE | Wave Life Sciences | $108.30M | $8.70M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | - |
| IMTX | Immatics | $54.00M | $30.45M |
| SNDX | Syndax Pharmaceuticals | $23.68M | $37.96M |
| IMNM | Immunome | $9.04M | $2.93M |
| TSHA | Taysha Gene Therapies | $8.33M | $1.99M |
| NUVB | Nuvation Bio | $7.87M | $4.83M |
| ATAI | Atai Life Sciences | - | $1.55M |
| ELVN | Enliven Therapeutics | - | - |
| SYRE | Spyre Therapeutics | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |